vanilmandelic acid has been researched along with Attention Deficit Disorder with Hyperactivity in 9 studies
Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.
Attention Deficit Disorder with Hyperactivity: A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty boys (mean age, 9 +/- 2 years) with attention deficit disorder with hyperactivity received three weeks each of dextroamphetamine sulfate (0." | 5.06 | Fenfluramine and dextroamphetamine treatment of childhood hyperactivity. Clinical and biochemical findings. ( Donnelly, M; Keysor, CS; Murphy, DL; Oliver, J; Potter, WZ; Rapoport, JL, 1989) |
| "2 years) with Attention Deficit Disorder With Hyperactivity during an initial placebo period, after four weeks of treatment with either dextroamphetamine sulfate (N=5) or a monoamine oxidase inhibitor (N=9) and at the end of a subsequent two-week placebo "washout" period." | 5.05 | Treatment of hyperactive children with monoamine oxidase inhibitors. II. Plasma and urinary monoamine findings after treatment. ( Ismond, D; Karoum, F; Linnoila, M; Murphy, DL; Potter, WZ; Rapoport, JL; Zametkin, A, 1985) |
| "Children with attention deficit disorder with hyperactivity were given either methylphenidate hydrochloride or dextroamphetamine sulfate to compare the effects on urinary excretion of catecholamines, indoleamines, and phenylethylamine (PEA)." | 3.67 | Stimulants, urinary catecholamines, and indoleamines in hyperactivity. A comparison of methylphenidate and dextroamphetamine. ( Brown, GL; Chuang, LW; Karoum, F; Linnoila, M; Rapoport, JL; Wyatt, RJ; Zametkin, AJ, 1985) |
| "Children with attention deficit disorder with hyperactivity were treated with methylphenidate HCl (0." | 3.67 | The effect of methylphenidate on urinary catecholamine excretion in hyperactivity: a partial replication. ( Hamburger, SD; Zametkin, AJ, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xin, RE | 1 |
| Pliszka, SR | 1 |
| Maas, JW | 2 |
| Javors, MA | 2 |
| Rogeness, GA | 2 |
| Baker, J | 1 |
| Elia, J | 1 |
| Borcherding, BG | 1 |
| Potter, WZ | 3 |
| Mefford, IN | 1 |
| Rapoport, JL | 4 |
| Keysor, CS | 2 |
| Zametkin, A | 1 |
| Murphy, DL | 2 |
| Linnoila, M | 2 |
| Karoum, F | 2 |
| Ismond, D | 1 |
| Macedo, CA | 1 |
| Fischer, C | 1 |
| Harris, WR | 1 |
| Zametkin, AJ | 2 |
| Brown, GL | 1 |
| Chuang, LW | 1 |
| Wyatt, RJ | 1 |
| Donnelly, M | 1 |
| Oliver, J | 1 |
| Hamburger, SD | 1 |
| Wender, PH | 1 |
| Epstein, RS | 1 |
| Kopin, IJ | 1 |
| Gordon, EK | 1 |
3 trials available for vanilmandelic acid and Attention Deficit Disorder with Hyperactivity
| Article | Year |
|---|---|
Stimulant drug treatment of hyperactivity: biochemical correlates.
Topics: 3,4-Dihydroxyphenylacetic Acid; Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetam | 1990 |
Treatment of hyperactive children with monoamine oxidase inhibitors. II. Plasma and urinary monoamine findings after treatment.
Topics: Amines; Attention Deficit Disorder with Hyperactivity; Child; Clinical Trials as Topic; Clorgyline; | 1985 |
Fenfluramine and dextroamphetamine treatment of childhood hyperactivity. Clinical and biochemical findings.
Topics: Attention Deficit Disorder with Hyperactivity; Blood Platelets; Child; Clinical Trials as Topic; Dex | 1989 |
6 other studies available for vanilmandelic acid and Attention Deficit Disorder with Hyperactivity
| Article | Year |
|---|---|
[Preliminary study on urinary vanilmandelic acid levels in minimal brain dysfunction].
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Female; Humans; | 1982 |
Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety.
Topics: Anxiety Disorders; Arousal; Attention Deficit Disorder with Hyperactivity; Child; Epinephrine; Femal | 1994 |
Attention deficit disorder symptoms and urine catecholamines.
Topics: Attention Deficit Disorder with Hyperactivity; Catecholamines; Child; Dopamine; Dopamine beta-Hydrox | 1989 |
Stimulants, urinary catecholamines, and indoleamines in hyperactivity. A comparison of methylphenidate and dextroamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Attention Deficit Disorder with Hyperactivity; Catecholamines; Child | 1985 |
The effect of methylphenidate on urinary catecholamine excretion in hyperactivity: a partial replication.
Topics: 3,4-Dihydroxyphenylacetic Acid; Attention Deficit Disorder with Hyperactivity; Catecholamines; Child | 1988 |
Urinary monoamine metabolites in children with minimal brain dysfunction.
Topics: Adolescent; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Brain Damage, Chro | 1971 |